For the last decade, Sendai virus (Kohler & Milstein, 1975) and polyethylene glycol (PEG) (Kenneth, 1979) have been used as fusogenic agents, to fuse lymphocytes with a myeloma cell line to yield hybridoma cells that produce monoclonal antibodies of predetermined specificity. However, these fusion procedures have inherent limitations, including a relatively low yield of hybrids, loss of viability, and loss of secretory properties in the hybridoma cells. These disadvantages illustrate the need for a new approach YO the fusion technique.
Vienken et al. (1983) have reported the successful fusion of many different cell types by a new electrical technique. In this procedure, cells are brought into close contact by dipole-dipole interactions in an alterating electric field and they are then fused by the application of a very short duration square pulse, that induces reversible electrical breakdown of cell membranes, resulting in fusion.
We report here an investigation into the technical advantages of using the novel technique of electrically induced cell fusion to obtain hybridoma cells for the production of monoclonal antibodies. In particular, antibodies to the glucose transport carrier of human erythrocytes (a membrane-spanning glycoprotein, of subunit M, 55 000) and to ankyrin, a peripheral membrane protein of human erythrocytes that links spectrin to band 3. We further compare the characteristics of these monoclonal antibodies to those produced against the same antigens using PEG as the fusogen, in order to determine whether electrofusion yields an increase in the frequency of production of hybrids and a decrease in cell damage during fusion.
NSI myeloma (HGPRT-negative) and mouse spleen lymphocytes were resuspended at a 50: 1 ratio in either the presence or absence of protease in a non-electrolyte medium (300 mM-rnannitol + 0.1 mM-CaCI, + 0.1 mMMgCI,) and subjected to an inhomogeneous, alternating electrical field, 10&200V/cm. A single, square pulse of Abbreviation used: PEG, polyethylene glycol.
Vol. 14 40 ps duration and 5 kV/cm strength was then applied (when using a medium containing pronase or dispase to stabilize the cells; Zimmermann & Pilwat 1981). Alternatively, in the absence of protease, five 1 kV/cm pulses of 40 ,us duration and 1 s intervals were used. The cells were cultured in RPMI 1640 medium, on 96-well plates. Successful proliferation of electrofused hybridomas was observed, which were prepared in the presence of proteases (0.5 mg of pronase/ml or 10 pg or 5 pg of dispase/ml) using a 50 : 1 ratio of lymphocyte/myeloma in the fusion chamber. Electrofusion of NSI myeloma and mouse spleen lymphocytes in the absence of protease, using a regime of five breakdown pulses (0.5 or 1 .O kV/cm) of 40 ps duration and at 1 s intervals also resulted in hybrid proliferation in culture.
In a comparative experiment, antibodies were successfully produced against the glucose transport carrier and against ankyrin using both PEG fusion and electrofusion techniques (Table 1) . Enzyme-linked immunosorbant Table 1 . A comparison of PEG-fused and electrofused hybridomas Mouse spleen lymphocytes, immunized with purified glucose transport carrier (Fusion 1) or purified ankyrin (Fusion 2), were electrofused and PEG-fused with NSI myeloma as described in the text. The resulting hybridomas were screeened for antibody production, using an enzyme-linked immunosorbant assay against a purified preparation of glucose transport carrier (Fusion 1) or purified ankyrin (Fusion 2) and against human erythrocyte ghosts. The data are expressed as a percentage positive wells of total wells assayed. assays showed that a slightly higher proportion of hybridomas obtained in the electrofusion experiments were directed against the antigen of interest, by comparison with hybridomas produced using PEG. Hybridomas secreting antibody aginst the purified ankyrin preparation, obtained by electrofusion and by using PEG, were cloned by limiting dilution techniques, using a feeder layer of non-immune mouse spleen lymphocytes. Clones obtained using polyethylene glycol were further characterized using Western blotting procedures on total proteins from human erythrocyte ghosts and on purified ankyrin, separated by polyacrylamidegel electrophoresis (Fairbanks Method; Fairbanks et al., 197 1). Two clones demonstrated specific antigen-binding patterns to band 2.1 of the human erythrocyte ghost proteins, i.e. to ankyrin.
In summary, conditions for the successful electrofusion of NSI myeloma and mouse spleen lymphocytes have been established. Also, hybridomas producing antibodies specifically against the glucose transport carrier and against ankyrin from human erythrocytes have been produced and cloned using the electrofusion procedure. However, in these initial studies, the method has not proved to be markedly superior to the use of PEG.
The epidermal growth factor (EGF) receptor is a 170000-M , membrane-spanning glycoprotein found in a variety of cell types. It is capable of specifically binding EGF, an event which is followed by a variety of cellular responses, including stimulation of ion and nutrient transport, enhancement of the phosphorylation of cellular proteins, changes in cell morphology, enhancement of protein biosynthesis and, after prolonged stimulation, DNA synthesis and cell division (Carpenter & Cohen, 1979; Adamson & Rees, 1981; Schlessinger et al., 1983) .
We have previously described the reconstitution of the EGF receptor in artificial lipid bilayers (Panayotou et al., 1985) . The EGF receptor was isolated from a human epidermal carcinoma cell line (A431) in the presence of the non-ionic detergent octylglucoside, added to a mixture of phospholipids, and cholesterol and liposomes were formed by detergent dialysis. It was shown that the EGF receptor is inserted in the lipid bilayer with the majority of EGF-binding sites facing outside the liposomes and that the reconstituted receptor retains its ability to bind EGF in a specific manner.
We report here the use of this reconstitution system to transfer the EGF receptor to the receptor-negative mouse fibroblast cell line, NR6 (Pruss & Herschman, 1977) . We were interested to know whether the extraction and prurification of the EGF receptor from the cell membrane followed by its incorporation into an artificial lipid bilayer would have an effect on its ability to generate a mitogenic response upon addition of EGF. We also wanted to know whether the human EGF receptor would be functional and able to interact with components within a mouse fibroblast cell.
NR-6 cells in Dulbecco's modified Eagle's medium Abbreviations used; EGF, epidermal growth factor; DMEM, Dulbecco's modified Eagles medium; FCS, foetal calf serum; PBS, phosphate-buffered saline.
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